共 50 条
- [44] MEASURE: a multi-centre, single-arm, observational, 96 week, phase IV study to evaluate treatment adherence when using RebiSmartTM for self-injection of subcutaneous interferon-β 1a in multi-dose cartridges in subjects with relapsing multiple sclerosis JOURNAL OF NEUROLOGY, 2011, 258 : 265 - 266